Most Read Articles
Roshini Claire Anthony, 04 Apr 2019

In addition to an intensive weight loss programme, the use of continuous positive airway pressure (CPAP) could improve absolute weight loss in individuals with obesity and obstructive sleep apnoea (OSA), according to a study presented at ENDO 2019.

4 days ago
The ketogenic and Modified Atkin’s diets are effective treatments for children with refractory epilepsy of genetic aetiology, a new study suggests.
5 days ago
Extremely premature neonates who have been exposed to pre-eclampsia in utero are at high risk of developing severe respiratory distress syndrome and severe bronchopulmonary dysplasia, according to a study.
Pearl Toh, 3 days ago
A contraceptive vaginal system (Annovera) releasing a combination of segesterone acetate and ethinyl estradiol (SA/EE) effectively inhibits ovulation up to a year even at low systemic levels of SA, reports a review study presented at ENDO 2019.

HKU investigators discovered antiviral compound effective against MERS, SARS, avian flu

Dr. Joseph Delano Fule Robles
23 Jan 2019
From left: Dr Jasper Fuk-Woo Chan, Prof Kwok-Yung Yuen, Dr Shuofeng Yuan and Dr Hin Chu

Scientists from the Department of Microbiology, University of Hong Kong (HKU) recently discovered a compound with broad antiviral activity against viruses causing Middle East Respiratory Syndrome (MERS), avian flu (H7N9), severe acute respiratory syndrome (SARS) and Zika fever.

The compound, called AM580, is a synthetic retinoid acid receptor-alpha (RAR-α) agonist that interferes with viruses’ lipid metabolism through interaction with sterol regulatory element binding proteins (SREBP). [Nat Commun 2019, doi: 10.1038/s41467-018-08015-x]

“Profound increases in major lipogenic enzymes are associated with viral infections and AM580 was shown to antagonize these changes, thereby reducing virus replication,” the investigators explained.

In vitro experiments showed that treatment with AM580 reduced MERS viral titres in cell culture supernatants and decreased expression of viral nucleoproteins. AM580’s antiviral effect was also observed in other important viruses causing epidemics, such as SARS, H1N1 and Zika viruses. 

In vivo experiments in MERS-infected mice treated with AM580 showed less body weight loss (p<0.05) and lower lung tissue virus titres and viral loads (p<0.01) vs control mice.

Moreover, mice challenged with H7N9 (avian flu) viruses then treated with AM580 had higher survival rates (60 percent vs 0 percent; p<0.01) and lower viral loads in lung tissues (p<0.01) vs control mice.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 04 Apr 2019

In addition to an intensive weight loss programme, the use of continuous positive airway pressure (CPAP) could improve absolute weight loss in individuals with obesity and obstructive sleep apnoea (OSA), according to a study presented at ENDO 2019.

4 days ago
The ketogenic and Modified Atkin’s diets are effective treatments for children with refractory epilepsy of genetic aetiology, a new study suggests.
5 days ago
Extremely premature neonates who have been exposed to pre-eclampsia in utero are at high risk of developing severe respiratory distress syndrome and severe bronchopulmonary dysplasia, according to a study.
Pearl Toh, 3 days ago
A contraceptive vaginal system (Annovera) releasing a combination of segesterone acetate and ethinyl estradiol (SA/EE) effectively inhibits ovulation up to a year even at low systemic levels of SA, reports a review study presented at ENDO 2019.